Literature DB >> 30541402

Reference Guide for Integrating Continuous Glucose Monitoring Into Clinical Practice.

Davida F Kruger1, Steve V Edelman2, Deborah A Hinnen3, Christopher G Parkin4.   

Abstract

PURPOSE: Large randomized trials have demonstrated the efficacy of continuous glucose monitoring (CGM) in persons with type 1 diabetes and insulin-treated type 2 diabetes. The purpose of this article is to provide basic knowledge about CGM technology, discuss the use of CGM data in clinical practice, and direct clinicians to online resources that provide comprehensive information and tools relevant to patient selection, education/training, and reimbursement.
CONCLUSIONS: Effective use of CGM requires all members of the health care team to become knowledgeable and skilled in integrating CGM into their practices and in teaching their patients how to safely incorporate CGM use into their daily diabetes self-management.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30541402     DOI: 10.1177/0145721718818066

Source DB:  PubMed          Journal:  Diabetes Educ        ISSN: 0145-7217            Impact factor:   2.140


  7 in total

1.  The Changing Landscape of Glycemic Targets: Focus on Continuous Glucose Monitoring.

Authors:  Pamela R Kushner; Davida F Kruger
Journal:  Clin Diabetes       Date:  2020-10

2.  A Review of the First Long-term Implantable Continuous Glucose Monitoring System Available in the United States.

Authors:  Kevin Cowart
Journal:  J Diabetes Sci Technol       Date:  2019-12-13

3.  Review of the Long-Term Implantable Senseonics Continuous Glucose Monitoring System and Other Continuous Glucose Monitoring Systems.

Authors:  Jeffrey I Joseph
Journal:  J Diabetes Sci Technol       Date:  2020-04-29

Review 4.  The road from intermittently scanned continuous glucose monitoring to hybrid closed-loop systems. Part B: results from randomized controlled trials.

Authors:  Francesca De Ridder; Marieke den Brinker; Christophe De Block
Journal:  Ther Adv Endocrinol Metab       Date:  2019-08-30       Impact factor: 3.565

Review 5.  Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range.

Authors:  Tadej Battelino; Thomas Danne; Richard M Bergenstal; Stephanie A Amiel; Roy Beck; Torben Biester; Emanuele Bosi; Bruce A Buckingham; William T Cefalu; Kelly L Close; Claudio Cobelli; Eyal Dassau; J Hans DeVries; Kim C Donaghue; Klemen Dovc; Francis J Doyle; Satish Garg; George Grunberger; Simon Heller; Lutz Heinemann; Irl B Hirsch; Roman Hovorka; Weiping Jia; Olga Kordonouri; Boris Kovatchev; Aaron Kowalski; Lori Laffel; Brian Levine; Alexander Mayorov; Chantal Mathieu; Helen R Murphy; Revital Nimri; Kirsten Nørgaard; Christopher G Parkin; Eric Renard; David Rodbard; Banshi Saboo; Desmond Schatz; Keaton Stoner; Tatsuiko Urakami; Stuart A Weinzimer; Moshe Phillip
Journal:  Diabetes Care       Date:  2019-06-08       Impact factor: 19.112

6.  Beyond A1C: A Practical Approach to Interpreting and Optimizing Continuous Glucose Data in Youth.

Authors:  Iman Al-Gadi; Sruthi Menon; Sarah K Lyons; Daniel J DeSalvo
Journal:  Diabetes Spectr       Date:  2021-05-25

7.  Practical Considerations for Initiating and Utilizing Flash Continuous Glucose Monitoring in Clinical Practice.

Authors:  Carol H Wysham; Davida F Kruger
Journal:  J Endocr Soc       Date:  2021-04-09
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.